As part of the TLJ 2.0, Workstream 6 has been considering the management of patients with HLA antibodies, with the aim of publishing a clinical guideline. On 28 August a meeting will take place in Milan with experts in the field and the wider clinical community to discuss the latest draft, after which the guideline will be revised accordingly.
We welcome input from ALL members of our community. Places are limited, so if you would like to attend in person or virtually, you can already pre-register and we will prioritise your registration (deadline: 23 July EOB).
Download the programme here.
